Description
Manufacturer
NOVARTIS SAGLIK(TURKEY)
Registraction Number
MAL15125061ARZ
Content:
Entresto (sacubitril/valsartan) is a combination medication used to treat heart failure. Each 50 mg film-coated tablet contains 24.3 mg of sacubitril and 25.7 mg of valsartan (as sacubitril valsartan sodium salt complex).
Indications:
- Heart Failure: Treatment of heart failure with reduced ejection fraction (HFrEF) in adults to reduce the risk of cardiovascular death and hospitalization.
- Hypertension: Treatment of high blood pressure in adults.
Instructions:
- Dosage: The typical starting dose is 49/51 mg (one 50 mg tablet) twice daily. The dose may be doubled after 2-4 weeks to the target dose of 97/103 mg (two 50 mg tablets) twice daily.
- Consistency: Take the tablet at the same time each day.
- Adherence: Do not miss doses, as this can increase the risk of heart failure.
- Monitoring: Regular monitoring of blood pressure, kidney function, and electrolytes is recommended.
More detail about Complete Wellness